SLC35D1 CRISPR/Cas9 KO Plasmid (h): sc-407065
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- SLC35D1 CRISPR/Cas9 Knockout (KO) Plasmid (h) is a pool of plasmids, each encoding Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed for maximum knockout efficiency using sequences derived from the GeCKO v2 library
- gRNA sequences direct Cas9 to induce site-specific double-strand breaks (DSBs) in the SLC35D1 genomic locus, resulting in gene knockout through non-homologous end joining (NHEJ)
- The puromycin resistance and RFP genes are flanked by LoxP sites, enabling removal of selection markers via Cre recombinase (Cre Vector: sc-418923) after establishing stable knockout cell lines
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
SLC35D1 CRISPR/Cas9 KO Plasmid (h) | sc-407065 | 20 µg | $397.00 |
Overview
SLC35D1 encodes a Golgi-resident nucleotide sugar transporter that mediates import of UDP-glucuronic acid and UDP-N-acetylgalactosamine into the lumen to support glycosaminoglycan biosynthesis. By controlling substrate availability for glycosyltransferases, SLC35D1 influences proteoglycan assembly, extracellular matrix organization, and cartilage development. Disruption of SLC35D1 is linked to skeletal dysplasia phenotypes consistent with impaired chondroitin sulfate production and altered proteoglycan composition. As a result, SLC35D1 is frequently studied in pathways related to Golgi glycosylation, matrix biology, and differentiation of chondrocytes and other connective tissue lineages.
SLC35D1 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the SLC35D1 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the SLC35D1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the SLC35D1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish SLC35D1 protein expression.
This CRISPR knockout system enables efficient generation of SLC35D1-deficient cell models for investigation of SLC35D1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
Key Features
- sgRNAs targeting SLC35D1 exon(s) critical for SLC35D1 function
- Co-expression of SpCas9 and sgRNA from a single plasmid for simplified delivery
- GFP reporter for identification of transfected cells
- Pool of plasmids targeting multiple SLC35D1 genomic sites to improve knockout efficiency
- Compatible with delivery by transfection
Design Variants
CRISPRs +/- HDRs
- gRNAs encoded by SLC35D1 CRISPR/Cas9 KO Plasmid (h) and SLC35D1 CRISPR/Cas9 KO Plasmid (h2) target distinct sites within the SLC35D1 locus. One or both targeting designs may be available. See Related Products for availability.
- HDR donor constructs encoded by SLC35D1 HDR Plasmid (h) and SLC35D1 HDR Plasmid (h2) contain a puromycin resistance cassette and an RFP reporter flanked by SLC35D1 homology arms to support homology-directed repair at defined SLC35D1 target sites corresponding to the CRISPR/Cas9 KO designs. HDR donor availability may vary. See Related Products for availability.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.